EBGLYSS
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for EBGLYSS, covering 2024-09-13 to 2026-03-20. Get the full timeline:
Most recent: EMA Authorised: Ebglyss (Lebrikizumab) — Almirall, S.A.
4 regulatory and trial events tracked for EBGLYSS, covering 2024-09-13 to 2026-03-20. Get the full timeline:
Most recent: EMA Authorised: Ebglyss (Lebrikizumab) — Almirall, S.A.